Literature DB >> 2773963

Antimicrobial misuse in patients with positive blood cultures.

W C Dunagan1, R S Woodward, G Medoff, J L Gray, E Casabar, M D Smith, C A Lawrenz, E Spitznagel.   

Abstract

PURPOSE: Inappropriate antimicrobial use was examined among a randomly and prospectively selected cohort of patients with at least one positive result of blood cultures. This misuse was then analyzed with respect to hospital charges and length of stay (LOS). PATIENTS AND METHODS: The study consisted of 70 patients (average age, 58.5 years) who had not undergone bone marrow transplantation. Patient charts were reviewed daily for the following information: clinical signs and symptoms of infection, pertinent laboratory data, culture results, detailed data on each antimicrobial in every antimicrobial regimen and their appropriateness, hospital charges, LOS, diagnostic and procedure codes, and discharge status. Three severity of illness variables were generated. Inappropriate antimicrobial use was described according to one of 12 categories.
RESULTS: The percent of antimicrobial misuse, defined as the proportion of days of administration of antimicrobials on which one or more antimicrobials were judged inappropriate, was found to be 22.3%. After adjustment for severity of illness and diagnosis, this average inappropriateness correlated with 4.2 additional hospitalization days and $5,368 additional hospital charges.
CONCLUSION: Our results cannot distinguish among several possible reasons for these associations, including direct causality (e.g., toxicity and prolonged hospitalization for antimicrobial use) and indirect links such as inappropriate utilization of other resources and influences of severity of illness on antimicrobial use not accounted for in our equations. Nevertheless, the magnitude of the association gives import to the desirability of further studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773963     DOI: 10.1016/s0002-9343(89)80146-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  30 in total

Review 1.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

3.  Identifying drug usage patterns in the intensive care unit.

Authors:  H J Mann; E T Wittbrodt
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

4.  The use of pharmaceuticals in critical care. The importance of outcome prediction models.

Authors:  G D Clifton; K Blumenschein
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

Review 5.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Improving early management of bloodstream infection: a quality improvement project.

Authors:  Jane Minton; James Clayton; Jonathan Sandoe; Hugh Mc Gann; Mark Wilcox
Journal:  BMJ       Date:  2008-02-23

7.  Direct identification of bacterial isolates in blood cultures by using a DNA probe.

Authors:  T E Davis; D D Fuller
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Strategies for controlling antibiotic use in a tertiary-care paediatric hospital.

Authors:  S A Diamond; B J Hales
Journal:  Paediatr Child Health       Date:  1997-05       Impact factor: 2.253

Review 9.  Nursing home-acquired pneumonia. Treatment options.

Authors:  T J Marrie; K L Slayter
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

10.  Effects of an operational multidisciplinary team on hospital antibiotic use and cost in France: a cluster controlled trial.

Authors:  Sibylle Bevilacqua; Béatrice Demoré; Marie-Line Erpelding; Emmanuelle Boschetti; Thierry May; Isabelle May; Christian Rabaud; Nathalie Thilly
Journal:  Int J Clin Pharm       Date:  2011-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.